All the sessions from Transform 2021 are available on-demand now. Watch now.

Ardian , developer of a device that could help treat high blood pressure, has brought in $47 million in a third round of funding led by Medtronic and including Emergent Medical Partners , Advanced Technology Ventures , Morgenthaler Ventures and Split Rock Partners .

Based in Palo Alto, the company claims that its technology relieves hypertension and risk of coronary disease or stroke to a greater degree than drug treatments like ACE inhibitors and beta blockers.

Ardian has raised $66 million to date.


VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more
Become a member